Real‐world efficacy of ustekinumab and vedolizumab in pediatric and young adult patients with inflammatory bowel disease
Journal of Pediatric Gastroenterology and Nutrition · 2025-11 · 81 (5) · 1197-1207
DOI: 10.1002/jpn3.70198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 20.08.2025. Verfasst von Diane Hsu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Gastroenterology, Hepatology and Nutrition, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Ustekinumab, Antibodies, Monoclonal, Humanized, Gastrointestinal Agents, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Objectives
Ustekinumab and vedolizumab are used off‐label for pediatric inflammatory bowel disease (PIBD). Real‐world data are needed to determine their positioning and safety. To assess the (1) 6‐month and 1‐year clinical outcome on ustekinumab and vedolizumab in PIBD based on Pediatric Ulcerative Colitis Activity Index, short Pediatric Crohn's Disease Activity Index, and calprotectin, and (2) secondary measures including safety and endoscopy.
Methods
Retrospective chart review of children and young adults with inflammatory bowel disease (IBD) treated at a pediatric academic hospital and two outpatient practices. Patients
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Gastroenterology, Hepatology and Nutrition, Stanford University, Stanford, California, USA.
- Quantitative Sciences Unit, Stanford University, Stanford, California, USA.
ORCID-Profile: Diane Hsu, Alka Goyal
Zitieren
APA
Hsu, D., Lee, J., Kotzen, A., Bensen, R., & Goyal, A. (2025). Real‐world efficacy of ustekinumab and vedolizumab in pediatric and young adult patients with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition, 81(5), 1197-1207. https://doi.org/10.1002/jpn3.70198
Vancouver
Hsu D, Lee J, Kotzen A, Bensen R, Goyal A. Real‐world efficacy of ustekinumab and vedolizumab in pediatric and young adult patients with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 2025;81(5):1197-1207. doi:10.1002/jpn3.70198
BibTeX
@article{Hsu2025,
author = {Hsu, Diane and Lee, Justin and Kotzen, Alison and Bensen, Rachel and Goyal, Alka},
title = {Real‐world efficacy of ustekinumab and vedolizumab in pediatric and young adult patients with inflammatory bowel disease},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2025},
volume = {81},
number = {5},
pages = {1197--1207},
doi = {10.1002/jpn3.70198}
}
EUVIMED